Drayton Wise
Corporate Officer/Principal at INSMED INCORPORATED
Net worth: 7 M $ as of 30/05/2024
Network origin in Drayton Wise first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Drayton Wise via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Chief Executive Officer Sales & Marketing | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | General Counsel | |
| AGENUS INC. | Biotechnology | Corporate Officer/Principal | |
| BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Administrative Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Bioconcept Ltd.
 Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Electronic Equipment/Instruments | Founder | |
| McGill University | College/University | Undergraduate Degree | |
| Central Michigan University | College/University | Masters Business Admin | |
| Charter Oak State College | College/University | Undergraduate Degree | |
| The College of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Rider University | College/University | Masters Business Admin Masters Business Admin | |
| University of Phoenix | College/University | Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Zambia | College/University | Doctorate Degree | |
Insmed Ltd.
 Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The Pennington School | College/University | Director/Board Member | |
| The Boys & Girls Clubs of Philadelphia | Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| University of Maryland School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Aim At Melanoma Foundation | Director/Board Member | ||
| Cepmed | Chief Executive Officer | ||
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Michigan State University College of Law | College/University | Graduate Degree | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BAUDAX BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Breath Therapeutics GmbH
 Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| SAVARA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 34 |
| Canada | 10 |
| United Kingdom | 4 |
| Ireland | 3 |
| France | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 150 |
| Corporate Officer/Principal | 72 |
| Independent Dir/Board Member | 63 |
| Undergraduate Degree | 30 |
| Chairman | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Myrtle Potter | 42 |
| Elizabeth Anderson | 25 |
| Donald Hayden | 23 |
| Christine Pellizzari | 22 |
| David Brennan | 19 |
| David McGirr | 16 |
| Matthew Pauls | 15 |
| Al Altomari | 14 |
| Steinar Johan Engelsen | 13 |
| Carol Schafer | 13 |
| Randall W. Whitcomb | 13 |
| Will Lewis | 12 |
| Clarissa Desjardins | 12 |
| Renu Gupta | 11 |
| Melvin Sharoky | 11 |
- Stock Market
- Insiders
- Drayton Wise
- Company connections
